News
Targeting a Key Driver of Cancer
It’s one of the most common and deadly drivers of cancer, yet it has eluded any drug therapies for decades. Now, buoyed by recent research breakthroughs and funding support, scientists are pushing harder than ever to target what has been called "undruggable." In the epic fight against cancer, a
Longer Telomeres Linked to Risk of Brain Cancer
New genomic research led by UC San Francisco scientists reveals that two common gene variants that lead to longer telomeres, the caps on chromosome ends thought by many scientists to confer health by protecting cells from aging, also significantly increase the risk of developing the deadly brain
Notable Progress Against Colorectal Cancer Shown in 10-Year National Study
Research led by a UC San Francisco investigator establishes a new benchmark in the treatment of patients with metastatic colorectal cancer and sets a new expectation for how long patients can live with the particularly lethal disease. The research, which spanned a decade, was unveiled at a plenary
UCSF to Present Advances in Prostate Cancer Treatment, Immunotherapy at Major Cancer Meeting
From prostate cancer to immunotherapy to genetic testing, UC San Francisco research is providing new insights and aiding in the development of new treatment strategies for cancer. Some of the latest research will be unveiled at the annual meeting of the American Society of Clinical Oncology (ASCO)
Peter Walter Receives Shaw Prize in Life Science and Medicine
A UC San Francisco professor of biochemistry and biophysics has received Asia’s highest scientific honor, the 2014 Shaw Prize in Life Science and Medicine, for his groundbreaking discovery of a system that makes "life and death decisions" for the cell. Peter Walter, PhD, who is also an investigator
E-Cigarettes Expose People to More than 'Harmless' Water Vapor and Should be Regulated, UCSF Scientists Find
In a major scientific review of research on e-cigarettes, UC San Francisco scientists found that industry claims about the devices are unsupported by the evidence to date, including claims that e-cigarettes help smokers quit. The review marks the first comprehensive assessment of peer-reviewed
New Cancer Immunotherapy Aims Powerful T Cells Against Tumors
Deadly skin cancers in mice shrank in response to a new treatment that may complement other "immunotherapies" developed recently to boost the body’s own defenses against disease threats, according to a new study published by UC San Francisco researchers in the May 2014 edition of the Journal of